Pinhole Pupilloplasty offers a simple, low-cost alternative to corneal transplants, providing clear vision with minimal complications.

Krystal Biotech announced the first patient has been dosed in EMERALD-1, its phase 1/2 clinical trial evaluating KB801 for ...

The World Health Organisation (WHO) on Friday (11th of July) announced that Burundi had effectively eliminated trachoma as a ...

Krystal Biotech climbs after dosing begins in a phase I/II trial for KB801, a gene therapy eye drop targeting neurotrophic keratitis.

What could have been a great day for actress Swastika Dutta as she was shooting for Aritra Mukherjee's Bhanupriya Bhooter Hotel, turned out to be a horrific nightmare, as she ended up having a corneal ...

References: Krystal Biotech announces first patient dosed in phase 3 clinical trial of KB803 for the treatment and prevention of corneal abrasions in patients with dystrophic epidermolysis bullosa.

Krystal Biotech announces dosing of first patient in Phase 3 trial evaluating KB803 for corneal abrasions in DEB patients.

IOLITE Phase 3 Study IOLITE is an intra-patient, double-blind, placebo-controlled, multicenter Phase 3 study with a crossover design to evaluate KB803, administered as an eye drop, for the treatment ...

Krystal Biotech Announces First Patient Dosed in Phase 3 Clinical Trial of KB803 for the Treatment and Prevention of Corneal Abrasions in Patients with Dystrophic ...

Hyderabad scientists achieve lasting cornea repair using stem cells The cornea, which is the clear, transparent outer layer at the front of the eye, can get severely damaged during accidents such as ...